Please use this identifier to cite or link to this item: https://dora.health.qld.gov.au/qldresearchjspui/handle/1/3354
Title: Incidence and outcomes of neuroblastoma in Australian children: A population-based study (1983-2015)
Authors: Youlden, D. R.
Karpelowsky, J.
Cundy, T. P.
Jones, B. C.
McBride, C. A.
Aitken, J. F.
Issue Date: 2020
Source: Jul 56, (7), 2020, p. 1046-1052
Pages: 1046-1052
Journal: J Paediatr Child Health
Abstract: AIM: Neuroblastoma predominantly affects younger children and exhibits heterogeneous behaviour. This study describes incidence and outcomes for neuroblastoma using national population-based data from the Australian Childhood Cancer Registry. METHODS: Deidentified data for all children (0-14 years) diagnosed with neuroblastoma and ganglioneuroblastoma from 1983 to 2015 were extracted. Cause-specific (CSS) and event-free survival were estimated using the cohort method. Adjusted hazard ratios were calculated using a multivariable flexible parametric survival model. Other outcomes investigated included recurrence and second primary malignancies (SPMs). RESULTS: The study cohort comprised 1269 patients. Age-standardised incidence rates remained steady across the study period at approximately 9.5 per million children per year. The proportion of patients with metastatic disease at diagnosis decreased from 63% in 1983-1995 to 42% by 2006-2015 (P < 0.001). CSS and event-free survival both improved significantly over time and reached 75% (95% confidence interval (CI) = 71-79%) and 71% (95% CI = 66-75%) at 5 years post-diagnosis, respectively, for children diagnosed between 2004 and 2013. Of patients achieving full remission, 28% relapsed with subsequent 5-year CSS of only 20%. Although SPMs were rare, neuroblastoma survivors carried a fivefold increased risk compared to cancer rates in the general population (standardised incidence ratio = 5.18, 95% CI = 3.01-8.91), with 7 of the 13 patients (54%) who were diagnosed with an SPM dying within 5 years. CONCLUSIONS: CSS for childhood neuroblastoma has improved substantially over time in Australia, but still remains lower than for most other types of childhood cancer. SPMs are uncommon and carry a better prognosis than relapse of the primary tumour.1440-1754Youlden, Danny R
Orcid: 0000-0002-2721-9083
Jones, Brendan C
Orcid: 0000-0002-2637-8859
Cundy, Thomas P
Karpelowsky, Jonathan
Aitken, Joanne F
McBride, Craig A
Orcid: 0000-0001-8377-1748
Journal Article
Australia
J Paediatr Child Health. 2020 Jul;56(7):1046-1052. doi: 10.1111/jpc.14810. Epub 2020 Feb 18.
DOI: 10.1111/jpc.14810
Keywords: *Neuroblastoma/epidemiology/therapy;Prognosis;Registries;childhood cancer;neuroblastoma;Humans;survival;Australia/epidemiologyChild;population-based cancer registry;Incidence;Infant;*Neoplasm Recurrence, Local
Type: Article
Appears in Sites:Children's Health Queensland Publications

Show full item record

Page view(s)

38
checked on Mar 13, 2025

Google ScholarTM

Check

Altmetric


Items in DORA are protected by copyright, with all rights reserved, unless otherwise indicated.